Impact Partnership Wealth »

Neurocrine Biosciences shares owned by Impact Partnership Wealth

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Impact Partnership Wealth from 13F filings

Historical chart of Impact Partnership Wealth investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Impact Partnership Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Impact Partnership Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $213k 1.3k 168.54
2024-06-30 $284k 2.1k 137.67
2023-06-30 $1.9k 20 94.25

More positions owned by Impact Partnership Wealth

Spdr Series Trust St Str Blo 1 Etf (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Spdr Series Trust St Str P400mid (SPMD)
Ssga Active Tr St St Sh Du Etf (PRSD)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds St Port Mark Etf (SPEM)
Vanguard Index Fds Growth Etf (VUG)
Select Sector Spdr Tr St Str Svc Etf (XLC)
Spdr Gold Tr Gold Shs (GLD)
Spdr Series Trust St Sho Treas Etf (SPTS)
Spdr Series Trust ST STR SP600 SML (SPSM)
Spdr Series Trust St Inter Etf (SPTI)
Select Sector Spdr Tr St Str Finl Etf (XLF)
Ishares Tr Mbs Etf (MBB)

View all positions for Impact Partnership Wealth

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences